دورية أكاديمية

Steroid Metabolism in Children and Adolescents With Obesity and Insulin Resistance: Altered SRD5A and 20α/20βHSD Activity.

التفاصيل البيبلوغرافية
العنوان: Steroid Metabolism in Children and Adolescents With Obesity and Insulin Resistance: Altered SRD5A and 20α/20βHSD Activity.
المؤلفون: Sumińska M; Department of Pediatric Diabetes and Obesity, Institute of Pediatrics, Poznan University of Medical Sciences, Poznan, Poland., Podgórski R; Centre for Innovative Research in Medical and Natural Sciences, University of Rzeszow, Rzeszow, Poland.; Department of Biochemistry, Institute of Medical Sciences, Collegium of Medical Sciences, University of Rzeszow, Rzeszow, Poland., Fichna P; Department of Pediatric Diabetes and Obesity, Institute of Pediatrics, Poznan University of Medical Sciences, Poznan, Poland., Fichna M; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland.
المصدر: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2021 Oct 26; Vol. 12, pp. 759971. Date of Electronic Publication: 2021 Oct 26 (Print Publication: 2021).
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [Lausanne : Frontiers Research Foundation]
مواضيع طبية MeSH: Insulin Resistance*, 20-alpha-Hydroxysteroid Dehydrogenase/*metabolism , 3-Oxo-5-alpha-Steroid 4-Dehydrogenase/*metabolism , Cortisone Reductase/*metabolism , Membrane Proteins/*metabolism , Pediatric Obesity/*enzymology, Adolescent ; Case-Control Studies ; Child ; Female ; Humans ; Male ; Steroids/urine
مستخلص: Alterations in glucocorticoid metabolism may contribute to the development of obesity and insulin resistance (IR). Obesity in turn affects the androgen balance. The peripheral metabolism of steroids is equally an important determinant of their bioavailability and activity. The aim of this study was to evaluate steroid metabolism in obese children and to define which enzyme alterations are associated with IR. Clinical characteristics and anthropometric measurements were determined in 122 obese children and adolescents (72 girls, 50 boys) aged 8 - 18 years. 26 of them (21.3%) were diagnosed with IR (13 boys, 13 girls). Routine laboratory tests were performed and 24h urinary steroid excretion profiles were analyzed by gas chromatography/mass spectrometry. Positive relationship between 5α-reductase (SRD5A) activity and IR was found. According to the androsterone to etiocholanolone (An/Et) ratio the activity of SRD5A was significantly increased in obese children with IR, but the difference remained insignificant once the 5α-dihydrotestosterone to testosterone (5αDHT/T) ratio was considered. Furthermore, this relationship persisted in boys but was not observed in girls. The activity of 20α-hydroxysteroid dehydrogenase (20αHSD) and 20β-hydroxysteroid dehydrogenase (20βHSD) was reduced only in obese girls with IR. Conclude, in the context of obese children and adolescents with IR, we surmise that increased SRD5A represents a compensatory mechanism to reduce local glucocorticoid availability. This phenomenon is probably different in the liver (restriction) and in the adipose tissue (expected increase in activity). We show significant changes in 20αHSD and 20βHSD activity in obese girls with IR, but it is difficult to clearly determine whether the activity of these enzymes is an indicator of the function in their ovaries or adrenal glands.
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2021 Sumińska, Podgórski, Fichna and Fichna.)
References: Int J Mol Sci. 2020 Jun 29;21(13):. (PMID: 32610579)
J Diabetes Res. 2015;2015:362375. (PMID: 26273668)
J Clin Endocrinol Metab. 1999 Jul;84(7):2414-8. (PMID: 10404813)
Chem Biol Interact. 2004 Mar 15;147(2):141-9. (PMID: 15013816)
Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E398-404. (PMID: 15494612)
Endocrinology. 1968 Mar;82(3):527-34. (PMID: 4384435)
Curr Opin Endocrinol Diabetes Obes. 2009 Oct;16(5):340-6. (PMID: 19584720)
Clin Endocrinol (Oxf). 2006 Jul;65(1):81-7. (PMID: 16817824)
Obesity (Silver Spring). 2007 Aug;15(8):1954-60. (PMID: 17712112)
PLoS One. 2018 Oct 11;13(10):e0203903. (PMID: 30308019)
N Engl J Med. 2013 Apr 18;368(16):1477-88. (PMID: 23506003)
Endocrine. 2017 Jan;55(1):19-36. (PMID: 27928728)
J Clin Endocrinol Metab. 2000 Nov;85(11):4093-8. (PMID: 11095438)
J Steroid Biochem Mol Biol. 1992 Dec;43(8):827-35. (PMID: 22217826)
BMC Pediatr. 2018 Sep 28;18(1):314. (PMID: 30266080)
Science. 2001 Dec 7;294(5549):2166-70. (PMID: 11739957)
Clin Med Insights Reprod Health. 2016 May 05;10:9-13. (PMID: 27168731)
J Clin Endocrinol Metab. 1999 Sep;84(9):3316-21. (PMID: 10487705)
J Clin Endocrinol Metab. 2005 Jan;90(1):264-70. (PMID: 15494462)
Int J Obes (Lond). 2015 Dec;39(12):1703-9. (PMID: 26155920)
PLoS One. 2013;8(1):e54851. (PMID: 23349977)
Endocrinology. 1968 Apr;82(4):844-59. (PMID: 5742200)
Physiol Rev. 2013 Jul;93(3):1139-206. (PMID: 23899562)
Steroids. 2014 Oct;88:83-9. (PMID: 25042470)
J Clin Endocrinol Metab. 2003 Dec;88(12):5907-13. (PMID: 14671189)
J Clin Endocrinol Metab. 2003 Jun;88(6):2384-92. (PMID: 12788832)
J Clin Endocrinol Metab. 2010 Dec;95(12):5189-98. (PMID: 20829185)
Mini Rev Med Chem. 2008 Feb;8(2):153-70. (PMID: 18289099)
J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):111-8. (PMID: 7626443)
PLoS One. 2012;7(2):e29531. (PMID: 22363403)
Am J Physiol Endocrinol Metab. 2010 Sep;299(3):E506-15. (PMID: 20570822)
Diabetes. 2008 Jun;57(6):1536-43. (PMID: 18340018)
Int J Mol Sci. 2013 Sep 02;14(9):17926-42. (PMID: 24002028)
J Endocrinol. 2004 Nov;183(2):331-42. (PMID: 15531721)
PLoS One. 2019 Mar 29;14(3):e0214549. (PMID: 30925175)
Hypertension. 1999 Jun;33(6):1364-8. (PMID: 10373217)
J Clin Endocrinol Metab. 2010 Oct;95(10):4729-35. (PMID: 20660036)
Trends Endocrinol Metab. 2008 Apr;19(3):96-9. (PMID: 18294861)
J Clin Endocrinol Metab. 1997 Feb;82(2):536-40. (PMID: 9024250)
J Clin Endocrinol Metab. 2003 Jun;88(6):2760-6. (PMID: 12788885)
Horm Res. 2004;62(3):107-12. (PMID: 15256820)
J Clin Endocrinol Metab. 2004 Sep;89(9):4755-61. (PMID: 15356090)
J Clin Endocrinol Metab. 2013 Apr;98(4):1631-40. (PMID: 23426618)
Endocr Rev. 2005 Jun;26(4):525-82. (PMID: 15632317)
J Biol Chem. 2019 Aug 9;294(32):12040-12053. (PMID: 31209107)
J Steroid Biochem Mol Biol. 2012 Oct;132(1-2):120-6. (PMID: 22381227)
Endocrinol Metab Clin North Am. 2014 Mar;43(1):75-102. (PMID: 24582093)
Reprod Biol Endocrinol. 2017 Mar 27;15(1):21. (PMID: 28347315)
Trends Endocrinol Metab. 2004 Nov;15(9):432-8. (PMID: 15519890)
J Clin Endocrinol Metab. 1993 Aug;77(2):341-6. (PMID: 8393881)
Mol Cell Endocrinol. 2020 Jun 15;510:110822. (PMID: 32315721)
Diabetes Care. 2020 Feb;43(2):405-410. (PMID: 31727688)
Arch Dis Child. 1974 Dec;49(12):946-54. (PMID: 4374898)
Adv Urol. 2012;2012:530121. (PMID: 22235201)
J Clin Endocrinol Metab. 1995 Dec;80(12):3469-75. (PMID: 8530585)
Gen Comp Endocrinol. 2001 Apr;122(1):109-15. (PMID: 11352559)
Endocrinology. 2007 Mar;148(3):976-88. (PMID: 17122075)
J Clin Endocrinol Metab. 2012 Mar;97(3):E367-75. (PMID: 22170725)
Endocrinology. 2017 Mar 1;158(3):627-639. (PMID: 27967235)
Acta Paediatr Hung. 1988-1989;29(3-4):395-403. (PMID: 3269272)
J Clin Endocrinol Metab. 1998 May;83(5):1806-9. (PMID: 9589697)
Gen Comp Endocrinol. 2010 May 1;166(3):489-97. (PMID: 19686747)
Endocr Rev. 1997 Feb;18(1):135-56. (PMID: 9034789)
Minerva Endocrinol. 2007 Sep;32(3):141-59. (PMID: 17912154)
J Chromatogr. 1986 Jun 20;379:91-156. (PMID: 3525596)
J Clin Endocrinol Metab. 2002 Jun;87(6):2701-5. (PMID: 12050237)
Diabetes. 2015 Feb;64(2):447-58. (PMID: 25239636)
Eur J Endocrinol. 2007 Sep;157(3):319-24. (PMID: 17766714)
J Histochem Cytochem. 2003 Nov;51(11):1425-36. (PMID: 14566015)
Eur J Endocrinol. 2011 Feb;164(2):197-203. (PMID: 21059865)
Obesity (Silver Spring). 2009 Sep;17(9):1678-83. (PMID: 19300426)
Acta Paediatr Hung. 1988-1989;29(3-4):383-93. (PMID: 3269271)
J Pediatr Endocrinol Metab. 2017 Feb 1;30(2):123-131. (PMID: 27984205)
Steroids. 1997 Jan;62(1):148-58. (PMID: 9029730)
Diabetes. 2008 Oct;57(10):2652-60. (PMID: 18633104)
J Clin Endocrinol Metab. 1988 Dec;67(6):1122-8. (PMID: 3142910)
Metabolism. 1980 Oct;29(10):980-5. (PMID: 6999293)
Pediatr Diabetes. 2003 Sep;4(3):119-25. (PMID: 14655269)
Int J Mol Sci. 2021 Jan 09;22(2):. (PMID: 33435513)
Obes Res. 2005 Sep;13(9):1523-6. (PMID: 16222053)
Int J Obes (Lond). 2014 Sep;38 Suppl 2:S39-47. (PMID: 25376219)
Molecules. 2013 Oct 25;18(11):13228-44. (PMID: 24165582)
Anim Reprod Sci. 2017 Sep;184:139-148. (PMID: 28735888)
Semin Reprod Med. 2002 Aug;20(3):249-54. (PMID: 12428205)
Nat Clin Pract Endocrinol Metab. 2005 Dec;1(2):92-9. (PMID: 16929377)
J Clin Endocrinol Metab. 2014 Jul;99(7):2391-9. (PMID: 24670085)
Diabetologia. 1985 Jul;28(7):412-9. (PMID: 3899825)
Endocr Res. 1998 Aug-Nov;24(3-4):549-57. (PMID: 9888536)
J Steroid Biochem Mol Biol. 2011 Mar;124(1-2):58-64. (PMID: 21262361)
J Clin Endocrinol Metab. 2004 Jun;89(6):2989-97. (PMID: 15181089)
Obesity (Silver Spring). 2013 Jan;21(1):E105-17. (PMID: 23505190)
Lancet. 2017 Dec 16;390(10113):2627-2642. (PMID: 29029897)
فهرسة مساهمة: Keywords: 20α-hydroxysteroid dehydrogenase; 20β-hydroxysteroid dehydrogenase; 5α-reductase; adolescents; children; insulin resistance; obesity; urinary steroid metabolites
المشرفين على المادة: 0 (Membrane Proteins)
0 (Steroids)
EC 1.1.1.149 (20-alpha-Hydroxysteroid Dehydrogenase)
EC 1.1.1.53 (Cortisone Reductase)
EC 1.3.99.5 (3-Oxo-5-alpha-Steroid 4-Dehydrogenase)
EC 1.3.99.5 (SRD5A1 protein, human)
تواريخ الأحداث: Date Created: 20211112 Date Completed: 20220218 Latest Revision: 20220218
رمز التحديث: 20240829
مُعرف محوري في PubMed: PMC8577858
DOI: 10.3389/fendo.2021.759971
PMID: 34764940
قاعدة البيانات: MEDLINE
الوصف
تدمد:1664-2392
DOI:10.3389/fendo.2021.759971